Alere Profile

84.3
USD 2.95  3.38%
95%
88.0
70%
86.1

Disposition of 35000 shares by Melissa Guerdan of Alere subject to Rule 16b-3

Alere Inc insider trading alert for disposition of employee stock option (right to buy) by Melissa Guerdan, SVP Global Quality Reg., on January 14, 2018. This event was filed by Alere Inc with SEC on 2017-10-03. Statement of changes in beneficial ownership - SEC Form 4. Melissa Guerdan is currently serves as vice president-global quality assurance of Alere Inc [view details]   

Alere Summary

Alere Inc (ALR) is traded on New York Stock Exchange in USA. It is located in MASSACHUSETTS, U.S.A and employs 9,200 people. Alere is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with total capitalization of 4.47 B. Alere Inc runs under Healthcare sector within Healthcare Services industry. This company has 87.58 M outstanding shares of which 3.37 M shares are presently shorted by investors with about 1.85 days to cover shorted positions. MORGAN STANLEY has about 491.85 M in cash with 93.75 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.62.
Check Alere Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Vanguard Group IncCommon Shares7.1 M362.5 M
Fmr LlcCommon Shares4.3 M217.5 M
Ubs Oconnor LlcPreferred Shares367.2 K146.6 M
View Alere Diagnostics

Selected Alere Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Alere Against Markets

Risk Adjusted
Performance Score (0 to 100)
15 
Chance of
Financial Distress (0 to 100%)
< 39% 
Equity ratings for Alere Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Alere Inc. offer professional diagnostic solutions and services for infectious and cardiometabolic disease, and toxicology in the United States, Europe, and internationally. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameAlere Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationMASSACHUSETTS, U.S.A
Business Address51 Sawyer Road Suite 200, Waltham, MA 02453, United States
ExchangeNew York Stock Exchange
CIK Number01145460.0
CUSIP01449J105
SectorHealthcare
IndustryHealthcare Services
BenchmarkDOW
Websitewww.alere.com
Contact Number781 647 3939
CurrencyUSD - US Dollar

Recommendations

Alere Analyst Recommendations
Target PriceAdvice# of Analysts
52.5Buy4Odds
Alere Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Alere Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas